The industry invites the regulators and pharmaceutical market experts for dialogue
8th Conference “State regulation and Russian pharmaceutical industry – 2016: continuing the dialogue”, the co-organizers of which are traditionally the Association of International Pharmaceutical Manufacturers and Association of Russian Pharmaceutical Manufacturers, as well as analytical company DSM Group, Research Institute of Health Organization and Medical Management of the Moscow City Health Department, under the support of Eurasian Economic Commission, will be held in Business-Hotel “Borodino” on March 31, 2016 (Moscow, Rusakovskaya street, b. 13/5).
Mundifarma became a member of AIPM
The Association of International Pharmaceutical Manufacturers (AIPM) announces extension to its member list. The decision to include "Mundifarma", a company specializing in the research and development of innovative drugs in various therapeutic areas, was made during AIPM General Managers Meeting.
AIPM and the Russian Patients Association signed Consensus Framework
During the VI Russian Congress of Patients “State and citizens in building patient-oriented health care in Russia”, which was held on November 12, 2015, Association of International Pharmaceutical Manufacturers and Russian Patients Association signed Consensus Framework of reciprocal understanding, which sets the following core ethical principles of activity: priority to patient’s interests, high standards of medical care, partnership in the health care sector in order to improve the availability and quality of medical service and overall development of healthcare system, as well as ensuring the independence of ethical standards of activities.
Introducing company interests, on which share it is necessary about 80 % made and sold in the world of pharmaceutical production and the medical equipment, AIPM considers as the priority cooperation with the Russian bodies of public health services, and also with legislative and executive branches of the power, for the purpose of working out of the program of creation of favorable conditions for sale and-or production of the international pharmaceutical companies in territory of the Russian Federation